Impaired physical health among methamphetamine users in comparison with the general population: The role of methamphetamine dependence and opioid use

Drug and Alcohol Review

Volumn 27, Issue 5, 2008, Pages 482-489

  McKetin, Rebecca ^a   Kelly, Erin ^a   McLaren, Jennifer ^a   Proudfoot, Heather ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Dependence; Methamphetamine; Physical health; Short Form 12; Substance use

Indexed keywords

CENTRAL STIMULANT AGENT; METHAMPHETAMINE;

ADULT; ARTICLE; AUSTRALIA; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DRUG ABUSE; FEMALE; HEALTH SURVEY; HUMAN; MALE; OPIATE ADDICTION; QUESTIONNAIRE; SEX DIFFERENCE; SOCIOECONOMICS;

ADULT; AMPHETAMINE-RELATED DISORDERS; AUSTRALIA; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; METHAMPHETAMINE; OPIOID-RELATED DISORDERS; POPULATION SURVEILLANCE; QUESTIONNAIRES; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 49549099787     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230801914776     Document Type: Article

References (37)

1. Karch SB, Stephens BG, Ho CH. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicological profiles. J Forensic Sci 1999;44:359-68.
2. Richards JR, Johnson EB, Stark RW, Derlet RW. Methamphetamine abuse and rhabdomyolysis in the ED: a 5-year study. Am J Emerg Med 1999;17:681-5.
3. Tokunaga I, Kubo S, Ishigami A, Gotohda T, Kitamura O. Changes in renal function and oxidative damage in methamphetamine-treated rat. Legal Med 2006;8:16-21.
4. Curtis EK. Meth mouth: a review of methamphetamine abuse and its oral manifestations. Gen Dent 2006;54:125-9.
5. Saini T, Edwards PC, Kimmes NS, Carroll LR, Shaner JW, Dowd FJ. Etiology of xerostomia and dental caries among methamphetamine abusers. Oral Health Prev Dent 2005;3:189-95.
6. Kaye S, Darke S. A comparison of the harms associated with the injection of heroin and amphetamines. Drug Alcohol Depend 2000;58:189-95.
7. Verachai V, Phutiprawan T, Theamboonlers A, et al. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand. Southeast Asian J Trop Med Public Health 2002;33:849-51.
8. Wada K, Greberman SB, Konuma K, Hirai S. HIV and HCV infection among drug users in Japan. Addiction 1999;94:1063-9.
9. Buchacz K, McFarland W, Kellogg TA, et al. Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS 2005;19:1423-4.
10. Koblin BA, Husnik MJ, Colfax G, et al. Risk factors for HIV infection among men who have sex with men. AIDS 2006;20:731-9.
11. Hirshfield S, Remien RH, Walavalkar I, Chiasson MA. Crystal methamphetamine use predicts incident STD infection among men who have sex with men recruited online: a nested case - control study. J Med Internet Res 2004;6:e41.
12. Baker A, Boggs TG, Lewin TJ. Characteristics of regular amphetamine users and implications for treatment. Drug Alcohol Rev 2001;20:49-56.
13. Kilbourne AM, McCarthy JF, Welsh D, Blow F. Recognition of co-occurring medical conditions among patients with serious mental illness. J Nerv Ment Dis 2006;194:598-602.
14. Australian Institute of Health and Welfare. 2004 National Drug Strategy Household Survey: detailed findings. Drug Statistics Series 16. Canberra: Australian Institute of Health and Welfare, 2005.
15. Pantiga C, Rodrigo LR, Cuesta M, Lopez L, Arias JL. Cognitive deficits in patients with hepatic cirrhosis and in liver transplant recipients. J Neuropsychiatry Clin Neurosci 2003;15:84-9.
16. Greenwell L, Brecht M-L. Self-reported health status among treated methamphetamine users. Am J Drug Alcohol Abuse 2003;29:75-104.
17. Vincent N, Shoobridge J, Ask A, Allsop S, Ali R. Physical and mental health problems in amphetamine users from metropolitan Adelaide, Australia. Drug Alcohol Rev 1998;17:187-95.
18. Sommers I, Baskin D, Baskin-Sommers A. Methamphetamine use among young adults: health and social consequences. Addict Behav 2006;31:1469-76.
19. Hall W, Hando J. Route of administration and adverse effects of amphetamine use among young adults in Sydney, Australia. Drug Alcohol Rev 1994;13:277-84.
20. Garrity TF, Leukefeld DSW, Carlson RG, Falck JW, Booth BM. Phsycial health, illicit drug use and demographic characteristics in rural stimulant users. Nat Rural Health Assoc 2007;23:99-107.
21. Darke S. Polydrug use and overdose: overthrowing old myths. Addiction 2003;98:711.
22. Darke S, Hall W. Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug Alcohol Depend 1995;39:231-5.
23. Darke S, Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug Alcohol Depend 1997;48:135-41.
24. Degenhardt L, Day C, Dietze P, et al. Effects of a sustained heroin shortage in three Australian States. Addiction 2005;100:908-20.
25. Ware JE, Kosinksi MMA, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
26. Burdine JN, Felix MJR, Abel AL, Wiltraut CJ, Musselman YJ. The SF-12 as a population health measure: an exploratory examination of potential for application. Health Serv Res 2000;35:885-904.
27. Sanderson K, Andrews G. Prevalence and severity of mental health-related impairment and relationship to diagnosis. Psychiatr Serv 2002;53:80-6.
28. Andrews G. A brief integer scorer for the SF-12: validity of the brief scorer in Australian community and clinic settings. Aust NZ J Public Health 2002;26:508-10.
29. Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J. The Severity of Dependence Scale (SDS) in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995;90:607-14.
30. Topp L, Mattick RP. Choosing a cutoff on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction 1997;92:839-845.
31. Ware JE, Kosinksi MMA, Keller SD. How to score the SF-12 Physical and Mental Health Summary Scales, 2nd edn. Boston: The Health Institute, New England Medical Centre, 1995.
32. Andrews G, Henderson S, Hall W. Prevalence, comorbidity, disability, and service utilisation: overview of the Australian National Mental Health Survey. Br J Psychiatry 2001;178:145-53.
33. STATA Corporation. Intercooled STATA version 8.0 for Windows. Texas: STATA Corporation, 2003.
34. Case A, Paxson C. Sex differences in morbidity and mortality. Demography 2005;42:189-214.
35. Spiers N, Jagger C, Clarke M, Arthur A. Are gender differences in the relationship between self-rated health and mortality enduring? Results from three birth cohorts in Melton Mowbray, United Kingdom. Gerontologist 2003;43:406-11.
36. McKetin R, Kelly E. Socio-demographic predictors of methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia. Drug Alcohol Rev 2007;25:161-8.
37. Johnson EM. Has the SF-36's role physical measure fallen short? J Public Health Med 1999;21:234.